Reply to F. Keane et al

Affiliations

¹ Vinod Ganju, MBBS, PASO Medical, Frankston Private Hospital, 5 Susono Way, Frankston, Victoria, Australia; Daniel Croagh, MBBS, PhD, Department of Surgery, Monash University, Clayton, Victoria, Australia; Joanne Lundy, MBBS, PhD, Department of Surgery, Faculty of Medicine, Nursing and Health Sciences, Monash University, Clayton, Victoria, Australia;Peninsula and Southeast Oncology, Frankston, Victoria, Australia.

Comment

Vinod Ganju et al. JCO Precis Oncol. 2022 Jun.

. 2022 Jun:6:e2200171.

doi: 10.1200/PO.22.00171.

¹ Vinod Ganju, MBBS, PASO Medical, Frankston Private Hospital, 5 Susono Way, Frankston, Victoria, Australia; Daniel Croagh, MBBS, PhD, Department of Surgery, Monash University, Clayton, Victoria, Australia; Joanne Lundy, MBBS, PhD, Department of Surgery, Faculty of Medicine, Nursing and Health Sciences, Monash University, Clayton, Victoria, Australia;Peninsula and Southeast Oncology, Frankston, Victoria, Australia.

No abstract available

Comment on

Exceptional Response to Olaparib and Pembrolizumab for Pancreatic Adenocarcinoma With Germline BRCA1 Mutation and High Tumor Mutation Burden: Case Report and Literature Review.
Lundy J, McKay O, Croagh D, Ganju V. Lundy J, et al. JCO Precis Oncol. 2022 Jan;6:e2100437. doi: 10.1200/PO.21.00437. JCO Precis Oncol. 2022. PMID: 35085003 Free PMC article. Review. No abstract available.
Homologous Recombination Deficiency in Pancreatic Cancer: Poly (ADP-ribose) Polymerase Inhibition, Checkpoint Inhibition, or a Combination of Both?
Keane F, Park W, O'Reilly EM. Keane F, et al. JCO Precis Oncol. 2022 Jun;6:e2200141. doi: 10.1200/PO.22.00141. JCO Precis Oncol. 2022. PMID: 35772046 No abstract available.